Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc

XERS

Market Cap$752.73M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xeris Biopharma Holdings IncXeris Biopharma Holdings Inc-15.9-128%4.7-7.7
$4.00

Target Price by Analysts

14.2% downsideXeris Biopharma Holdings Target Price DetailsTarget Price
$2.89

Current Fair Value

38% downside

Overvalued by 38% based on the discounted cash flow analysis.

Share Statistics

Market cap$752.73 Million
Enterprise Value$963.04 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.37
Beta0.91
Outstanding Shares152,445,935

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-15.9
PEG30.91
Price to Sales4.66
Price to Book Ratio-4.66
Enterprise Value to Revenue4.35
Enterprise Value to EBIT-38.95
Enterprise Value to Net Income-22
Total Debt to Enterprise0.28
Debt to Equity-7.65

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Xeris Pharmaceuticals Inc

CEO: paul Edick